Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01477060 | Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer | terminated | Phase 2 | 32 | Fondazione MichelangeloOTHER | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00827567 | Trial of RAD001 in Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 6 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00903656 |
| Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy |
| terminated |
| Phase 2 |
| 24 |
| Arbeitsgemeinschaft medikamentoese TumortherapieOTHER |
| 1 |
| Dec 24, 2013 |
| clinicaltrials |
| NCT00674206 | A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 6 | Emory UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | terminated | Phase 2 | 5 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00003432 | Immunotherapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Duke UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00726180 | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 15, 2013 | clinicaltrials |
| NCT00104624 | Docetaxel in Treating Older Women With Metastatic Breast Cancer | terminated | Phase 2 | 53 | UNICANCEROTHER | 3 | Sep 4, 2013 | clinicaltrials |
| NCT01301040 | Early Cardiac Toxicity of Adjuvant CT in Elderly BC. | terminated | Phase 2 | 2 | Jules Bordet InstituteOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00476827 | A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain | terminated | Phase 2 | 16 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00674557 | Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer | terminated | Phase 2 | 111 | Cancer Research UKOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00902668 | Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer | terminated | Phase 2 | 3 | Virginia Commonwealth UniversityOTHER | 0 | Jun 20, 2013 | clinicaltrials |
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 16 | National Cancer Centre, SingaporeOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01072838 | Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB | terminated | Phase 2 | 60 | SenoRx, Inc.INDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01416558 | Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) | terminated | Phase 2 | 66 | GBG Forschungs GmbHOTHER | 1 | May 22, 2013 | clinicaltrials |
| NCT01194427 | A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT00498901 | Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer | terminated | Phase 2 | 1 | University of WashingtonOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT01383408 | Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection | terminated | Phase 2 | 752 | Schillerhoehe HospitalOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00496379 | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases | terminated | Phase 2 | 15 | Nancy Lin, MDOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT01658358 | ErbB2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 15 | China Medical University HospitalOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00082667 | Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast | terminated | Phase 2 | 1 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00431795 | Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer | terminated | Phase 2 | 100 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00206414 | Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer | terminated | Phase 2 | 15 | Baylor Breast Care CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00206453 | Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer | terminated | Phase 2 | 25 | Baylor Breast Care CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00523809 | Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00025493 | S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer | terminated | Phase 2 | 27 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT00674414 | Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 82 | UNICANCEROTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00095888 | 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer | terminated | Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00227656 | Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00817362 | Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer | terminated | Phase 2 | 29 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 11, 2012 | clinicaltrials |
| NCT00793546 | Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer | terminated | Phase 2 | 42 | PfizerINDUSTRY | 11 | Nov 5, 2012 | clinicaltrials |
| NCT01006785 | Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer | terminated | Phase 2 | 15 | Dexa Medica GroupINDUSTRY | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00817531 | Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients | terminated | Phase 2 | 22 | Baylor Breast Care CenterOTHER | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00555841 | Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue | terminated | Phase 2 | 27 | Sigma-Tau Research, Inc.INDUSTRY | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00499681 | PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE | terminated | Phase 2 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00611715 | Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. | terminated | Phase 2 | 48 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | terminated | Phase 2 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00131924 | High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy | terminated | Phase 2 | 1 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00005608 | Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | terminated | Phase 2 | 9 | GlaxoSmithKlineINDUSTRY | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00607438 | A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 16 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00343512 | Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | terminated | Phase 2 | 34 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00657137 | APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)(APRiCOT-B) | terminated | Phase 2 | 12 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00739063 | Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer | terminated | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00453635 | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00955890 | Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer(cardioprotec) | terminated | Phase 2 | 12 | Fudan UniversityOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01254136 | Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer | terminated | Phase 1 / Phase 2 | 20 | Incyte CorporationINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Feb 20, 2014source: clinicaltrials